GNAS and pancreatic intraductal papillary-mucinous neoplasm: The GNAS mutations in cfDNA were detected in 11 (32%) of the all 34 IPMN patients and 10 (43%) of the 23 IPMN patients harboring GNAS mutation in their primary lesions (Fig. 1).